Biotech Week Boston highlights research progress in cell and gene therapy

By Samantha Black, PhD, ScienceBoard editor in chief

September 23, 2021 -- At Biotech Week Boston, ScienceBoard.net spoke with experts in cell and gene therapy technologies.

Biotech Week Boston is a collection of several industry-leading events, including BioProcess International, Cell & Gene Therapy Manufacturing & Commercialization US, and TIDES USA. The event was held at the Boston Convention Center from September 21-23. In attendance were life science professionals with expertise in discovery, financing, manufacturing, and clinical trials.

Video loading ...

We caught up with the following experts:

  • Stefano Menegatti, associate professor at North Carolina State University
  • Armon Sharei, founder and CEO of SQZ Biotech
  • Fabian Gerlinghaus, co-founder and CEO of Cellares
  • Andrew Tustian, director of viral process development at Regeneron Pharmaceuticals


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.